Table 2.
Group | Days post immunization (%) |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | ||
1 and 2 (1:1) |
M. bovis | 6/6 (100) |
6/6 (100) |
6/6 (100) |
6/6 (100) |
6/6 (100) |
5/6 (83.3) |
3/6 (50) |
3/6 (50) |
3/6 (50) |
1/6 (16.7) |
0/6 (0) |
0/6 (0) |
0/6 (0) |
0/6 (0) |
BoHV-1 | 6/6 (100) |
6/6 (100) |
6/6 (100) |
6/6 (100) |
6/6 (100) |
6/6 (100) |
6/6 (100) |
2/6 (33.3) |
2/6 (33.3) |
1/6 (16.7) |
1/6 (16.7) |
1/6 (16.7) |
0/6 (0) |
0/6 (0) |
|
3 and 4 (1:2) |
M. bovis | 6/6 (100) |
6/6 (100) |
6/6 (100) |
6/6 (100) |
6/6 (100) |
5/6 (83.3) |
4/6 (66.7) |
4/6 (66.7) |
3/6 (50) |
2/6 (33.3) |
0/6 (0) |
0/6 (0) |
0/6 (0) |
0/6 (0) |
BoHV-1 | 6/6 (100) |
6/6 (100) |
6/6 (100) |
6/6 (100) |
6/6 (100) |
6/6 (100) |
6/6 (100) |
3/6 (50) |
3/6 (50) |
2/6 (33.3) |
2/6 (33.3) |
1/6 (16.7) |
1/6 (16.7) |
0/6 (0) |
|
5 and 6 (2:1) |
M. bovis | 6/6 (100) |
6/6 (100) |
6/6 (100) |
6/6 (100) |
6/6 (100) |
6/6 (100) |
4/6 (66.7) |
4/6 (66.7) |
4/6 (66.7) |
2/6 (33.3) |
1/6 (16.7) |
0/6 (0) |
0/6 (0) |
0/6 (0) |
BoHV-1 | 6/6 (100) |
6/6 (100) |
6/6 (100) |
6/6 (100) |
6/6 (100) |
6/6 (100) |
6/6 (100) |
2/6 (33.3) |
2/6 (33.3) |
1/6 (16.7) |
1/6 (16.7) |
0/6 (0) |
0/6 (0) |
0/6 (0) |
|
7 (M. bovis HB150) |
3/3 (100) |
3/3 (100) |
3/3 (100) |
3/3 (100) |
3/3 (100) |
3/3 (100) |
3/3 (100) |
3/3 (100) |
2/3 (66.7) |
2/3 (66.7) |
0/3 (0) |
1/3 (33.3) |
0/3 (0) |
0/3 (0) |
|
8 (BoHV-1 gG-/tk-) |
3/3 (100) |
3/3 (100) |
3/3 (100) |
3/3 (100) |
3/3 (100) |
3/3 (100) |
3/3 (100) |
1/3 (33.3) |
2/3 (66.7) |
1/3 (33.3) |
1/3 (33.3) |
1/3 (33.3) |
0/3 (0) |
0/3 (0) |
|
11 (Mock) |
0/3 (0) |
0/3 (0) |
0/3 (0) |
0/3 (0) |
0/3 (0) |
0/3 (0) |
0/3 (0) |
0/3 (0) |
0/3 (0) |
0/3 (0) |
0/3 (0) |
0/3 (0) |
0/3 (0) |
0/3 (0) |